Moreover, SLC7A5 is included in one prognosis prediction test for breast cancer, called the Mammostrat test, which is an immunohistochemical multigene assay that analyzes five genes (p53, HTF9C, CEACAM5, NDRG1, and SLC7A5) [47]. This evidence concerns the gene CEACAM5 and breast carcinoma.